S

Smith+Nephew

Global medical devices for orthopedics

Trade Compliance Specialist

Full-TimeUpdated on 10/23/2026
$81.8k - $122.5k/yr+ Bonus
Junior
Bachelor's
Andover, MA, USA+2 moreMore locations: Mansfield, MA, USA | Memphis, TN, USA
HybridHybrid with regular onsite presence; candidates must live within a reasonable commuting distance of one of the listed locations.
Risk & ComplianceRegulatory Compliance & Ethics
No H1B Sponsorship

About the job

Requirements
  • A bachelor's degree in Business, International Business, Supply Chain, Logistics, Finance, Economics, Customs Administration, or a related field, or equivalent relevant experience.
  • At least one year of experience in Trade Compliance, Customs Compliance, Customs Brokerage, Import Operations, Logistics, or a related field.
  • Practical knowledge of U.S. customs requirements and import entry processes.
  • Working knowledge of Harmonized Tariff Schedule classification principles and the ability to gather product information, perform classification analysis, document conclusions, and support routine classification decisions.
  • Experience reviewing customs documentation and import entries for accuracy and completeness.
  • Ability to investigate discrepancies, organize supporting documentation, and communicate clearly with brokers and internal stakeholders.
  • Working knowledge of Microsoft Excel and Microsoft 365 applications.
  • Ability to manage multiple priorities, work independently on routine matters, and seek input appropriately for complex or higher-risk issues.
  • Ability to work onsite regularly at the assigned location; candidates should reside within a reasonable commuting distance of Andover, Massachusetts; Mansfield, Massachusetts; or Memphis, Tennessee.
  • Strong attention to detail and a proactive compliance mindset.
  • Confidence in conducting Harmonized Tariff Schedule classification analysis and trade compliance reviews.
  • Strong ownership, accountability, and follow-through.
  • Ability to balance business needs with regulatory compliance requirements.
  • Collaborative approach and willingness to expand expertise across trade compliance disciplines.
Responsibilities
  • Support timely and compliant customs clearance of import shipments into the United States and Canada.
  • Review commercial invoices, packing lists, transport documents, classification, value, country of origin, and trade program information for completeness and accuracy.
  • Respond to broker inquiries, documentation gaps, customs entry requirements, import restrictions, customs holds, and clearance escalations.
  • Coordinate with internal stakeholders and service providers to resolve issues promptly while maintaining compliance.
  • Maintain complete, organized, and audit-ready clearance records.
  • Perform post-entry audits to verify classification, valuation, country of origin, trade program eligibility, fees, and other declaration elements.
  • Document audit findings, investigate exceptions, and coordinate corrections with brokers and internal stakeholders.
  • Identify recurring errors and trends and support corrective and preventive actions.
  • Maintain audit trackers, metrics, and supporting documentation.
  • Support Post Summary Corrections, protests, and related post-entry activity as needed.
  • Serve as a day-to-day contact for designated customs brokers and support consistent execution of clearance instructions.
  • Monitor broker responsiveness, entry accuracy, open issues, and service levels through established metrics and scorecards.
  • Provide approved classification, origin, valuation, and trade program information and resolve data or documentation discrepancies.
  • Support broker reviews, onboarding, procedure updates, and remediation of recurring issues.
  • Maintain broker authorizations, instructions, contacts, and governance documentation.
  • Gather product specifications, composition details, function, technical documentation, bills of material, and other information needed to perform Harmonized Tariff Schedule classification assessments.
  • Perform Harmonized Tariff Schedule classification analysis using applicable interpretive rules, product information, and supporting documentation, and document the basis for classification decisions.
  • Work with Research and Development, Engineering, Manufacturing, Procurement, Supply Chain, and suppliers to obtain information needed for classification and origin decisions.
  • Support country of origin determinations by gathering manufacturing, component, sourcing, and process information and completing initial fact-based analysis.
  • Maintain classification and origin records, supporting documentation, and audit trails; collaborate with senior team members when an additional perspective is appropriate for complex, novel, or higher-risk matters.
  • Support the company's Customs Trade Partnership Against Terrorism program, including procedures, evidence, training records, and validation readiness, as assigned.
  • Assist with supply chain security assessments of facilities, suppliers, logistics providers, and other business partners.
  • Track identified gaps and corrective actions and follow up with stakeholders through closure.
  • Support annual reviews, risk assessments, security profile updates, and other program requirements.
  • Support export controls and sanctions activities, including restricted party screening, information gathering, recordkeeping, and escalation support, as assigned.
  • Assist with Export Control Classification Number data collection and initial assessment activities, collaborating with senior team members as appropriate.
  • Support internal audits, regulatory inquiries, training, procedures, and cross-functional projects.
  • Provide backup assistance across North America Trade Compliance based on business priorities.
Desired Qualifications
  • Exposure to Canadian customs requirements.
  • Experience independently performing Harmonized Tariff Schedule classifications.
  • U.S. Customs Broker License, or progress toward obtaining licensure.
  • Experience working directly with customs brokers.
  • Exposure to country of origin determinations, Customs Trade Partnership Against Terrorism, export controls, sanctions compliance, restricted party screening, or Export Control Classification Number classifications.
  • Experience with SAP, enterprise resource planning systems, or customs reporting tools.
  • Experience within the medical device, healthcare, life sciences, or another regulated industry.
  • Experience using Microsoft Copilot, Power BI, or similar productivity and reporting tools.

About the company

Smith+Nephew is a global medical technology company that designs and makes medical devices for orthopaedics, sports medicine, and advanced wound care. Its products help surgeons treat joints and soft tissues and support patient recovery, including knee repair systems, single-use negative pressure wound therapy devices, and other extremity orthopaedic products. These devices are used in hospitals and clinics to perform procedures and support healing, often after surgery or injury. The company differentiates itself with a broad, worldwide product portfolio and collaborations with healthcare organizations to improve care and efficiency for patients and providers. Its goal is to improve patient outcomes, streamline medical procedures, and expand access to advanced medical solutions around the world.

Company Size

10,001+

Company Stage

IPO

Headquarters

Watford, United Kingdom

Founded

1856

Get referred to Smith+Nephew

See people who can refer or advise you

Simplify Jobs

Simplify's Take

What believers are saying

  • Q1 2026 revenue reached $1.5 billion, and full-year guidance stayed intact on May 6.
  • New launches in 2026 include CORI XT, FLOW FLEXTEND, and ALLEVYN COMPLETE CARE.
  • August 2026 H1 results showed 4.6% growth, $200 million efficiency savings, and $500 million buyback.

What critics are saying

  • Reuters on August 4, 2026 cut revenue guidance to around 4% after weak U.S. knees.
  • Smith+Nephew’s finance chief John Rogers exits September 30, 2026, creating leadership churn.
  • A March 2026 humeral nail recall and older hip litigation expose recurring quality risk.

What makes Smith+Nephew unique

  • Smith+Nephew’s CORI XT robotics spans knee, shoulder, and future hip workflows.
  • Its ASC Solutions bundles facility design, financing, and clinical enablement for outpatient surgery.
  • ALLEVYN, RENASYS, and LEAF create a broad wound-care platform with measurable outcomes.

Help us improve and share your feedback! Did you find this helpful?

Benefits

  • Health Insurance
  • Dental Insurance
  • Vision Insurance
  • 401(k) Retirement Plan
  • 401(k) Company Match
  • Paid Vacation
  • Paid Holidays
  • Flexible Work Hours
  • Parental Leave
  • Fertility Treatment Support
  • Family Planning Benefits
  • Tuition Reimbursement

Company News

Yahoo Finance
Oct 23rd, 2026
Smith & Nephew's $22B talks to buy J&J's orthopaedics unit collapse over who would lead

Smith & Nephew's merger talks with Johnson & Johnson (J&J) over its orthopaedics unit collapsed over who would lead the combined company, the Financial Times reported. The sides had reportedly agreed on the main financial terms and the deal structure. J&J wanted Namal Nawana, who runs its orthopaedics unit and formerly led Smith & Nephew, to lead the business. Smith & Nephew wanted current chief executive officer Deepak Nath to stay. Smith & Nephew's offer valued J&J's hip and knee unit at up to $22 billion, almost double its own market value. J&J shareholders would have owned 50.1% of the combined company. J&J is leaning toward spinning off the unit as DePuy Synthes, targeting mid-2027. Reuters reported the unit sought around $20 billion and drew private equity interest. Both companies declined to comment.

Yahoo Finance
Oct 18th, 2026
Three undervalued UK stocks for October 2026: Morgan Sindall, Shell, Smith & Nephew

Simply Wall St has named three London-listed stocks it says trade below estimated fair value based on future cash flows: Morgan Sindall Group, Shell, and Smith & Nephew. The screen flags 23 more companies not covered. Morgan Sindall Group, a £1.8b construction and regeneration firm, saw its secured order book rise 39% to £12bn. Its Partnership Housing arm ties it to long-term contracts, though policy changes and planning delays pose risks. Shell has a market value of about £225.1b and revenue of $443.2b. Its LNG portfolio exceeds 60 million tons. Smith & Nephew, valued at £9.1b, relies on repeat implant procedures. New products drove 75% of first-half growth.

Yahoo Finance
Oct 6th, 2026
Smith+Nephew launches CARTIHEAL AGILI-C cartilage repair implant in Europe

Smith+Nephew has launched its CARTIHEAL AGILI-C Cartilage Repair Implant in Europe. The product, already introduced in the US during 2024, will be featured at the International Cartilage Regeneration & Joint Preservation Society Summit in Porto, Portugal from 8-10 October. The implant, composed of aragonite (a naturally occurring calcium carbonate), acts as a biphasic scaffold to repair cartilage, restore bone and relieve pain. A recent study published in the American Journal of Sports Medicine showed the implant resulted in higher overall Knee injury and Osteoarthritis Outcome Scores versus surgical standard of care for all time points out to 60 months. The implant will initially launch in twelve countries including Austria, Belgium, France, Germany, Ireland, Italy, Luxembourg, Netherlands, Portugal, Spain, Switzerland and the UK.

Kalkine Media
Sep 10th, 2026
Smith+Nephew issues $700M 5.750% bonds due 2036 to refinance 2030 senior notes

Smith & Nephew has issued $700 million in senior notes with a 5.750% coupon maturing in 2036, netting $690.9 million after underwriting fees. The FTSE 100 medical technology firm will primarily use proceeds to fund a tender offer for its existing 2.032% senior notes due 2030, with remaining funds allocated to general corporate purposes. The refinancing replaces lower-yield debt with higher-coupon notes, reflecting current credit market conditions. BofA Securities, J.P. Morgan Securities, Mizuho Securities USA, and SMBC Nikko Securities America managed the transaction, which closed on 11 September 2026. Founded in Hull in 1856, Smith & Nephew operates across orthopaedics, sports medicine, ENT, and advanced wound management. The company employs approximately 17,000 people across 100 countries and reported annual sales of $6.2 billion in 2025.

Ticker Report
Sep 3rd, 2026
Corient Private Wealth LP Makes New $2 Million Investment in Smith & Nephew SNATS, Inc. $SNN

Corient Private Wealth LP purchased a new stake in Smith & Nephew SNATS, Inc. (NYSE:SNN – Free Report) during the 2nd quarter, according to the company in its most recent disclosure with the Securities and Exchange Commission. The firm purchased 31,871 shares of the medical equipment provider’s stock, valued at approximately $1,999,000. Other large investors […]